Atlas Trials

Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens

Clinical trial NCT06923280 · RECRUITING

Trial details

NCT number
NCT06923280
Sponsor
Huashan Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2025-08-25
Primary completion
2027-12-31
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.